[HTML][HTML] Medical management of COVID-19: evidence and experience

S Bose, S Adapa, NR Aeddula, S Roy… - Journal of clinical …, 2020 - ncbi.nlm.nih.gov
Coronavirus disease 2019 is caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), and this infectious disease is termed COVID-19 in short. On a global scale …

[HTML][HTML] Current COVID-19 treatments: Rapid review of the literature

Y Dong, A Shamsuddin, H Campbell… - Journal of Global …, 2021 - ncbi.nlm.nih.gov
Background As SARS-CoV-2 continues to spread worldwide, it has already resulted in over
110 million cases and 2.5 million deaths. Currently, there are no effective COVID-19 …

[HTML][HTML] Clinical management of COVID-19: a review of pharmacological treatment options

AM Heustess, MA Allard, DK Thompson, PS Fasinu - Pharmaceuticals, 2021 - mdpi.com
Since the outbreak and subsequent declaration of COVID-19 as a global pandemic in March
2020, concerted efforts have been applied by the scientific community to curtail the spread of …

Review of registered clinical trials for the treatment of COVID‐19

F Babaei, M Mirzababaei, M Nassiri‐Asl… - Drug Development …, 2021 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19) is a viral disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2). The disease was first reported in …

Treatment considerations for COVID-19: a critical review of the evidence (or lack thereof)

P Vijayvargiya, ZE Garrigos, NEC Almeida… - Mayo Clinic …, 2020 - Elsevier
The novel severe acute respiratory syndrome coronavirus 2 is causing a worldwide
pandemic that may lead to a highly morbid and potentially fatal coronavirus disease 2019 …

An updated review on COVID-19

MA Ebada, A Wadaa-Allah, E Bahbah… - … Formerly Current Drug …, 2021 - ingentaconnect.com
Coronavirus Disease (COVID-19) pandemic has affected more than seven million
individuals in 213 countries worldwide with a basic reproduction number ranging from 1.5 to …

[HTML][HTML] Potential therapeutic options for COVID-19: current status, challenges, and future perspectives

C Sarkar, M Mondal, M Torequl Islam… - Frontiers in …, 2020 - frontiersin.org
The COVID-19 pandemic represents an unprecedented challenge for the researchers to
offer safe, tolerable, and effective treatment strategies for its causative agent known as …

COVID-19 treatment: close to a cure? A rapid review of pharmacotherapies for the novel coronavirus (SARS-CoV-2)

Y Song, M Zhang, L Yin, K Wang, Y Zhou… - International journal of …, 2020 - Elsevier
Currently, there is no approved therapy for coronavirus disease 2019 (COVID-19). The
World Health Organization (WHO) therefore endorses supportive care only. However …

[HTML][HTML] Recent advances in management of COVID-19: A review

S Mouffak, Q Shubbar, E Saleh, R El-Awady - Biomedicine & …, 2021 - Elsevier
Abstract The coronavirus disease 2019 (COVID-19) pandemic caused and is still causing
significant mortality and economic consequences all over the globe. As of today, there are …

[HTML][HTML] Potential treatments for COVID-19; a narrative literature review

A Rismanbaf - Archives of academic emergency medicine, 2020 - ncbi.nlm.nih.gov
SARS-CoV-2 is a newly emerging human infectious coronavirus that causes COVID-19,
which has been recognized as a pandemic by the World Health Organization (WHO) on …